Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

With 26% Growth in H1, Neimeth Outshines Peers in Revenue Generation

Neimeth International Pharmaceuticals Plc emerged as the fastest-growing listed pharmaceutical company by revenue in the first half of 2026, recording a 26 per cent year-on-year increase in sales despite a

We haven't written up this one. This Day has the full story — the link below goes straight to it.

Read the original at thisdaylive.com →

More in Finance & Markets

More from Monday 10 August →